# Ketamine Infusion vs Dexmedetomidine Infusion in Obese Patients Undergoing Bariatric Surgery

> **NCT04576975** · PHASE3 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 90 (actual)

## Conditions studied

- Morbid Obesity
- Surgery

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Dexmedetomidine
- **DRUG:** Normal Saline 0.9%

## Key facts

- **NCT ID:** NCT04576975
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-20
- **Primary completion:** 2021-12-30
- **Final completion:** 2022-07-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2021-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04576975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04576975, "Ketamine Infusion vs Dexmedetomidine Infusion in Obese Patients Undergoing Bariatric Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04576975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*